Sai Life Sciences

Sai Life Sciences

861.70
+6.05
(0.71%)
Market Cap
17,965.23 Cr
EPS
8.83
PE Ratio
73.25
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
943.00
52 Week Low
636.10
PB Ratio
8.40
Debt to Equity
0.41
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,593.40
#1 3,82,310.03
33.36
#1 54,729.00
9.71
#1 10,980
-19.84
43.49
6,031.50
1,60,117.37
69.07
9,712.00
18.67
2,191
26.74
38.09
1,563.80
1,26,309.35
23.25
28,409.50
7.12
5,291
9.88
49.52
3,591.70
1,21,559.45
61.04
11,539.40
6.99
1,911
19.91
57.02
1,304.20
1,08,844.76
#1 19.00
33,741.20
16.73
5,725
1.26
58.05
2,608.50
1,07,660.29
56.54
12,744.20
#1 20.90
2,007
-18.14
57.82
1,039.60
1,04,608.09
22.38
23,511.00
18.55
4,615
2.60
66.25
1,979.70
90,412.00
24.19
22,909.50
13.74
3,306
#1 51.64
54.20
31,255.00
66,414.69
44.84
6,684.70
9.64
1,414
11.55
34.59
5,320.50
63,614.56
28.03
13,458.30
3.70
2,216
21.39
60.00

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
20.01 %
Net Income Growth
728.00 %
Cash Flow Change
19.37 %
ROE
658.04 %
ROCE
94.05 %
EBITDA Margin (Avg.)
35.89 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
395
443
288
406
449
589
506
Expenses
287
315
254
293
320
422
376
EBITDA
108
128
34
112
129
167
131
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
24 %
Depreciation
31
31
31
36
34
38
38
Interest
23
21
21
21
23
11
12
Profit Before Tax
53
76
-18
55
72
119
81
Tax
13
20
-5
14
18
31
20
Net Profit
40
56
-14
42
54
88
61
EPS in ₹
2.19
31.00
-0.74
2.22
2.89
4.24
2.90

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
1,410
1,817
2,157
2,187
2,275
3,160
Fixed Assets
641
753
751
1,037
1,180
1,488
Current Assets
613
804
944
964
945
1,505
Capital Work in Progress
91
194
410
151
107
125
Investments
0
0
0
2
2
2
Other Assets
679
870
997
997
987
1,545
Total Liabilities
1,410
1,817
2,157
2,187
2,275
3,160
Current Liabilities
467
599
713
759
740
733
Non Current Liabilities
149
356
565
540
560
299
Total Equity
794
863
879
888
975
2,128
Reserve & Surplus
777
845
861
870
957
2,108
Share Capital
16
18
18
18
18
21

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
239
-150
-1
75
-80
-24
79
Investing Activities
-158
-262
-260
-102
-99
-191
-536
Operating Activities
129
116
-36
105
219
263
314
Financing Activities
268
-4
296
72
-201
-95
301

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
35.15 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
14.58 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
21.64 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
6.56 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
22.07 %
No of Share Holders
70
5,72,970
82
1,40,677
1,26,380

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2025 791.55 856.35
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 815.20 792.85

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS7 days ago
Corrigendum To The Notice Of The 26Th Annual General Meeting.7 days ago
Company -Updates7 days ago
Company-Updates8 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 28, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Reg. 34 (1) Annual Report.Aug 18, 2025
Notice Of 26Th Annual General Meeting Of The Members Of Sai Life Sciences Limited To Be Held On Thursday 11Th September 2025 At 10.30 A.M. (IST)Aug 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 14, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On 30 June 2025.Aug 07, 2025
Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On 30 June 2025Aug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 23, 2025
Board Meeting Intimation for Notice Of The Board MeetingJul 21, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Clarification On Increase In VolumeJul 03, 2025
Clarification sought from Sai Life Sciences LtdJul 03, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 27, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 27, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 27, 2025
Closure of Trading WindowJun 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 23, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 20, 2025
Intimation For Commencement Of Commercial Operation Of The Second Phase Of The Production - (Unit IV Bidar Facility)Jun 20, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 17, 2025
Ratification Of ESOP Scheme And Extension Of Benefits To The Employees Of Its Subsidiaries.Jun 17, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 17, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Reply To Ingovern Research Services Pvt Ltd On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018Jun 10, 2025
Announcement under Regulation 30 (LODR)-AllotmentJun 09, 2025
Reply To SES On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018Jun 09, 2025
Reply To Iias On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018Jun 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025

Technical Indicators

RSI(14)
Neutral
51.25
ATR(14)
Less Volatile
29.16
STOCH(9,6)
Neutral
42.88
STOCH RSI(14)
Neutral
32.61
MACD(12,26)
Bearish
-5.05
ADX(14)
Weak Trend
23.10
UO(9)
Bearish
50.17
ROC(12)
Downtrend And Accelerating
-7.47
WillR(14)
Neutral
-63.09

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Small Cap Fund Direct- Growth
0.00%
-5772731
-0.71%
-0.67%
Invesco India Smallcap Fund Direct - Growth
0.00%
-3869451
-4.13%
-2.99%
Invesco India Large & Mid Cap Fund Direct-Growth
0.00%
-3127699
-3.16%
-2.87%
Nippon India Multi Cap Fund Direct-Growth
0.00%
-3056223
-0.54%
-0.52%
Invesco India Mid Cap Fund Direct-Growth
0.00%
-2887698
-2.99%
-2.75%
Nippon India Pharma Fund Direct-Growth
0.00%
-2555745
-2.36%
-2.31%
DSP Healthcare Fund Direct - Growth
0.00%
-1703020
-4.32%
-4.31%
HSBC Small Cap Fund Direct-Growth
0.00%
-976747
-0.48%
-0.45%
Axis Flexi Cap Fund Direct-Growth
0.72%
765403
0.50%
0.52%
HSBC Multi Cap Fund Direct - Growth
0.00%
-753650
-1.23%
-1.17%
Invesco India Multicap Fund Direct-Growth
0.00%
-727248
-1.44%
0.00%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
2.10%
706395
1.26%
1.31%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
0.84%
656395
0.84%
0.84%
Mirae Asset Healthcare Fund Direct - Growth
0.00%
-646462
-1.80%
-1.99%
Invesco India Flexi Cap Fund Direct - Growth
0.00%
-644479
-1.52%
-1.53%
HSBC Large and Mid Cap Fund Direct - Growth
0.00%
-597062
-1.12%
-1.06%
HDFC Multi Cap Fund Direct - Growth
0.00%
-577771
-0.25%
-0.24%
Axis Small Cap Fund Direct-Growth
1.22%
535782
0.22%
0.53%
HDFC Innovation Fund Direct-Growth
0.00%
-492458
-1.63%
0.00%
Mirae Asset Multicap Fund Direct - Growth
0.00%
-483217
-0.99%
-1.27%
Bandhan Large & Mid Cap Fund Direct-Growth
0.00%
-470778
-0.38%
-0.35%
HDFC Large and Mid Cap Fund Direct- Growth
0.00%
-435717
-0.13%
-0.13%
Nippon India Balanced Advantage Fund Direct-Growth
0.00%
-420000
-0.36%
0.00%
HDFC Pharma And Healthcare Fund Direct - Growth
0.00%
-368087
-1.54%
-1.59%
Mirae Asset Small Cap Fund Direct-Growth
0.00%
-333300
-1.33%
-1.44%